Compound ID | 894
ABI-0185N
Class: Rifamycin
| Spectrum of activity: | Gram-positive |
| Details of activity: | RNA synthesis inhibitors; aimed for treatment of sexually transmitted infections |
| Description: | Jerse AE, Veit S, Van Duzer J, Murphy CK. Efficacy of novel rifamycins in experimental Neisseria gonorrhoeae infection. 44th-ICAAC 2004;209 |
| Institute where first reported: | ActivBiotics, Inc., USA |
| Year first mentioned: | 2004 |
| Highest developmental phase: | Preclinical |
| Development status: | Inactive |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/substance/349988029 |
| Citation: |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.